MedTrace Logo

The Effects of Different Methods Used in Pediatric Oral Drug Administration

NCT06251245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-03-05

No results posted yet for this study

Summary

The aim of this study is to determine the effect of the use of spoons and oral injectors on the level of fear in children with fever in oral medication administration.

Conditions

  • Children, Only
  • Fear

Interventions

PROCEDURE

Oral Injector

* Admission of a child with fever to the pediatric inpatient ward * Obtaining parental consent * Completing the patient identification data collection form * Obtaining the child's consent * Applying the "Child Fear Scale" to the child * Measuring the child's pulse and SpO2 * Applying the "Child Fear Scale" to the parent * Explaining the procedure using the educational therapeutic play method before oral medication administration * Administering the "Child Fear Scale" to the child and parent before oral medication administration * Measurement of the child's pulse and SpO2 * • Experimental Group (Giving the medicine orally to the child with an Oral Injector) * Application of the "Child Fear Scale" to the child and parent after oral medication administration * Measurement of the child's pulse and SpO2

PROCEDURE

Spoon

* Admission of a child with fever to the pediatric inpatient ward * Obtaining parental consent * Completing the patient identification data collection form * Obtaining the child's consent * Applying the "Child Fear Scale" to the child * Measuring the child's pulse and SpO2 * Applying the "Child Fear Scale" to the parent * Explaining the procedure using the educational therapeutic play method before oral medication administration * Administering the "Child Fear Scale" to the child and parent before oral medication administration * Measurement of the child's pulse and SpO2 * Control Group (Giving the medicine orally to the child with an oral medication spoon) * Application of the "Child Fear Scale" to the child and parent after oral medication administration * Measurement of the child's pulse and SpO2

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2024-06-16
Completion
2024-06-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06251245 on ClinicalTrials.gov